12/16/2024
3:11 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/04/2024
6:27 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/27/2024
11:26 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
3:55 PM | GREAT POINT PARTNERS LLC (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
| Form SC 13G/A | |
10/03/2024
8:22 PM | Gangolli Julian S (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
THURMAN RANDY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | HILZINGER KURT J (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
10/03/2024
7:30 PM | Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Faisal Ghiath (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Auffarth Gerd (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/03/2024
7:30 PM | Haller Julia A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
3:53 PM | KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
6:48 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
7:41 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
6:25 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form DEF 14A | |
05/15/2024
4:19 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/06/2024
11:15 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form EFFECT | |
05/01/2024
5:02 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:18 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
04/17/2024
8:38 PM | Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
Syntone Ventures LLC (Filed by)
| Form SC 13D/A | |
04/17/2024
7:21 PM | Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Syntone Ventures LLC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
4:21 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
04/15/2024
3:53 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:27 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 424B5 | |
04/07/2024
11:15 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form EFFECT | |
04/02/2024
3:15 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
11:15 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form EFFECT | |
04/01/2024
3:53 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 424B3 | |
03/29/2024
1:16 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/29/2024
9:39 AM | Haddadin Yezan Munther (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
3:00 PM | Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
TANG CAPITAL PARTNERS LP (Filed by)
| Form SC 13G | |
03/26/2024
3:20 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2024
3:11 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/22/2024
4:00 PM | KENYON LAWRENCE A (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:00 PM | Evanson Jeff (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/22/2024
4:00 PM | Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
TRENARY C RUSSELL III (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/20/2024
4:24 PM | GMS Ventures & Investments (Filed by)
Outlook Therapeutics, Inc. (Subject)
Outlook Therapeutics (Subject)
| Form SC 13D/A | |
03/20/2024
4:20 PM | GMS Ventures & Investments (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
Sukhtian Ghiath M. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:14 PM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/11/2024
3:43 PM | Evanson Jeff (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Why I'm telling friends to avoid gold stocks (Ad) Back in November, gold made a tiny move of 1.6%.
But according to my backtesting by using a special type of gold trade, I would have seen a 141% gain in just a week.
It happened again in March. Gold nudged up 1.2%.
This time? A 104% overnight gain.
And in June? A 1% gold move turned into a 74% gain in two weeks.
Granted, there would have been smaller wins and those that did not work out, but you see, there's a reason I'm telling all my friends to hold off from buying gold or regular gold stocks right now.
There's a more lucrative way to play the gold market as we enter a new breakout period.
It's all about catching what I call "Acceleration Cycles." And if you’d like to get your hands on this, here you go, the complete breakdown. |
03/08/2024
3:18 PM | Huang Andong (Reporting)
Outlook Therapeutics, Inc. (Issuer)
Outlook Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/08/2024
5:59 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form DEF 14A | |
02/08/2024
6:00 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form ARS | |
01/24/2024
5:02 AM | Outlook Therapeutics, Inc. (Filer)
Outlook Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
